Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Dyslipidemia

Free Subscription Articles published in Metabolism Retrieve available abstracts of 20 articles: HTML format

Single Articles

June 2024
1. EZHILARASAN D
   Deciphering the molecular pathways of saroglitazar: A dual PPAR alpha/gamma agonist for managing metabolic NAFLD.
   Metabolism. 2024;155:155912.
   PubMed     Abstract available
   
   
   November 2023
2. ZUO F, Wang Y, Xu X, Ding R, et al
   CCDC92 deficiency ameliorates podocyte lipotoxicity in diabetic kidney disease.
   Metabolism. 2023 Nov 10:155724. doi: 10.1016/j.metabol.2023.155724.
   PubMed     Abstract available
   
   
   July 2023
3. WANG YD, Wu LL, Mai YN, Wang K, et al
   miR-32-5p induces hepatic steatosis and hyperlipidemia by triggering de novo lipogenesis.
   Metabolism. 2023 Jul 12:155660. doi: 10.1016/j.metabol.2023.155660.
   PubMed     Abstract available
   
   
   December 2022
4. ZHANG J, Wu Y, Zhang J, Zhang R, et al
   ABCA1 deficiency-mediated glomerular cholesterol accumulation exacerbates glomerular endothelial injury and dysfunction in diabetic kidney disease.
   Metabolism. 2022 Dec 12:155377. doi: 10.1016/j.metabol.2022.155377.
   PubMed     Abstract available
   
   
   
5. HUANGFU G, Jaltotage B, Pang J, Lan NSR, et al
   Hepatic fat as a novel marker for high-risk coronary atherosclerotic plaque features in familial hypercholesterolaemia.
   Metabolism. 2022;139:155370.
   PubMed     Abstract available
   
   
   November 2022
6. YE J, Zhuang X, Li X, Gong X, et al
   Novel metabolic classification for extrahepatic complication of metabolic associated fatty liver disease: A data-driven cluster analysis with international validation.
   Metabolism. 2022;136:155294.
   PubMed     Abstract available
   
   
   October 2022
7. LARSSON SC, Michaelsson K, Mola-Caminal M, Hoijer J, et al
   Genome-wide association and Mendelian randomization study of fibroblast growth factor 21 reveals causal associations with hyperlipidemia and possibly NASH.
   Metabolism. 2022;137:155329.
   PubMed     Abstract available
   
   
   September 2022
8. TRICO D, Mengozzi A, Baldi S, Bizzotto R, et al
   Lipid-induced glucose intolerance is driven by impaired glucose kinetics and insulin metabolism in healthy individuals.
   Metabolism. 2022;134:155247.
   PubMed     Abstract available
   
   
   July 2022
9. BOUZONI E, Perakakis N, Connelly MA, Angelidi AM, et al
   PCSK9 and ANGPTL3 levels correlate with hyperlipidemia in HIV-lipoatrophy, are regulated by fasting and are not affected by leptin administered in physiologic or pharmacologic doses.
   Metabolism. 2022 Jul 9:155265. doi: 10.1016/j.metabol.2022.155265.
   PubMed     Abstract available
   
   
   January 2022
10. NEGI CK, Babica P, Bajard L, Bienertova-Vasku J, et al
    Insights into the molecular targets and emerging pharmacotherapeutic interventions for nonalcoholic fatty liver disease.
    Metabolism. 2022;126:154925.
    PubMed     Abstract available
    
    
    December 2021
11. BULLO M, Papandreou C, Garcia-Gavilan J, Ruiz-Canela M, et al
    Tricarboxylic acid cycle related-metabolites and risk of atrial fibrillation and heart failure.
    Metabolism. 2021;125:154915.
    PubMed     Abstract available
    
    
    
12. HANA CA, Tran LV, Molzer C, Mullner E, et al
    Serum metabolomics analysis reveals increased lipid catabolism in mildly hyperbilirubinemic Gilbert's syndrome individuals.
    Metabolism. 2021;125:154913.
    PubMed     Abstract available
    
    
    November 2021
13. YING Q, Chan DC, Barrett PHR, Watts GF, et al
    Unravelling lipoprotein metabolism with stable isotopes: tracing the flow.
    Metabolism. 2021;124:154887.
    PubMed     Abstract available
    
    
    July 2021
14. LIU S, Wang J, Wu S, Niu J, et al
    The progression and regression of metabolic dysfunction-associated fatty liver disease are associated with the development of subclinical atherosclerosis: A prospective analysis.
    Metabolism. 2021;120:154779.
    PubMed     Abstract available
    
    
    June 2021
15. PICHE ME, Clavel MA, Auclair A, Rodriguez-Flores M, et al
    Early benefits of bariatric surgery on subclinical cardiac function: Contribution of visceral fat mobilization.
    Metabolism. 2021;119:154773.
    PubMed     Abstract available
    
    
    May 2021
16. ALI S, Malloci M, Safiedeen Z, Soleti R, et al
    LPS-enriched small extracellular vesicles from metabolic syndrome patients trigger endothelial dysfunction by activation of TLR4.
    Metabolism. 2021;118:154727.
    PubMed     Abstract available
    
    
    March 2021
17. XU X, Dong Y, Ma N, Kong W, et al
    MiR-337-3p lowers serum LDL-C level through targeting PCSK9 in hyperlipidemic mice.
    Metabolism. 2021 Mar 25:154768. doi: 10.1016/j.metabol.2021.154768.
    PubMed     Abstract available
    
    
    
18. ONG KL, McClelland RL, Allison MA, Cushman M, et al
    Lipoprotein (a) and coronary artery calcification: prospective study assessing interactions with other risk factors.
    Metabolism. 2021;116:154706.
    PubMed     Abstract available
    
    
    February 2021
19. NAKATSU Y, Yamamotoya T, Okumura M, Ishii T, et al
    Prolyl isomerase Pin1 interacts with adipose triglyceride lipase and negatively controls both its expression and lipolysis.
    Metabolism. 2021;115:154459.
    PubMed     Abstract available
    
    
    
20. PICHE ME, Tardif I, Auclair A, Poirier P, et al
    Effects of bariatric surgery on lipid-lipoprotein profile.
    Metabolism. 2021;115:154441.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Dyslipidemia is free of charge.